APSR2026-639

 
Late-Breaking
Submitted
Oral Presentation
AO25-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1221032-46903-APSR2026-639_NKeicho_R11_7min_439897.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Naoto Keicho * Japan Anti-Tuberculosis Association The Research Institute of Tuberculosis Tokyo Japan
Akiko Miyabayashi - The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Department of Pathophysiology and Host Defense Tokyo Japan
Keiko Wakabayashi - The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Department of Pathophysiology and Host Defense Tokyo Japan
Masashi Ito - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Kozo Morimoto - Fukujuji Hospital, Japan Anti-Tuberculosis Association Respiratory Disease Center Tokyo Japan
Minako Hijikata - The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Department of Pathophysiology and Host Defense Tokyo Japan
 
 
 
 
 
 
 
 
 
Presenting Author Details
Naoto
Keicho
nkeicho-tky@umin.ac.jp
+819093607524
61-70
Japan
Original Research
Large genomic deletions as a major contributor to pathogenic variants in primary ciliary dyskinesia in Japan
Maximum 25 words
Abstract Content
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder characterized by chronic upper and lower airway infections, caused by pathogenic variants in genes involved in motile cilia function. Large genomic deletions are estimated to account for approximately 10% of disease-causing variants in congenital disorders. However, their contribution to PCD may vary across populations. This study aimed to clarify the frequency and characteristics of large deletions among pathogenic variants in Japanese patients with PCD.
We analyzed genetically confirmed or suspected PCD patients in a Japanese cohort using next-generation sequencing (NGS)-based approaches (N=227). Targeted resequencing was applied to identify variants, and candidate deletions were subsequently validated by long-range PCR. Breakpoints were determined through sequencing of PCR products. The distribution and frequency of large deletions were evaluated across known PCD-causing genes.
Large genomic deletions spanning at least one exon accounted for 51.1% of pathogenic variants in this cohort, indicating a substantial contribution to the genetic etiology of PCD in Japan. Notably, a 27,748 bp deletion spanning exons 1–4 of DRC1 (NC_000002.12:g.26398040_26425787del), presumed to be a founder variant, was frequently observed. In addition, less frequent but recurrent deletions were identified in other PCD-associated genes, including CCDC40 and CCDC39.
Large genomic deletions represent a significant fraction of pathogenic variants in Japanese PCD patients, exceeding the general estimates for congenital diseases. The high prevalence of a founder deletion in DRC1 and the presence of additional gene-specific deletions highlight a population-specific variant spectrum. These findings are clinically relevant for respiratory physicians, as accurate genetic diagnosis directly informs the evaluation of chronic airway disease, including bronchiectasis and recurrent respiratory infections.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
next-generation sequencing, pathogenic variants, and a founder deletion
maximum 3 keywords and no abbreviations, separated by commas
 
270